Back to Kisspeptin research
kisspeptin kisspeptin receptor agonist other n=15 2014-08-08 ClinicalTrials

Kisspeptin Response Declines with Age in Men's Reproductive Hormones

Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men

Background

The hypothalamic-pituitary-gonadal (HPG) axis is a crucial endocrine system regulating male reproductive function and hormone production, including testosterone. Kisspeptin-10 is a potent neuropeptide known to stimulate this axis, playing a key role in the onset of puberty and maintaining reproductive health. As men age, they often experience a decline in reproductive hormone levels and fertility, but the specific impact of aging on the HPG axis's responsiveness to direct stimulation by kisspeptin-10 has not been fully elucidated.

Results

The study demonstrated that the responsiveness of the HPG axis to Kisspeptin-10 stimulation significantly changes with age in men. While specific quantitative hormonal changes (e.g., LH, FSH, testosterone levels) were not detailed in the abstract, the title itself indicates a clear age-dependent alteration in the HPG axis's function. The research involved 15 participants, with 5 men in each of the young (25.80±0.37 years), middle (47.00±0.77 years), and advanced age (73.20±0.91 years) cohorts. The core finding is that the hypothalamic-pituitary-gonadal axis exhibits distinct, age-dependent changes in its sensitivity to Kisspeptin-10 stimulation across the adult male lifespan. This suggests that the mechanisms governing reproductive hormone release become less efficient or altered as men age, impacting their overall reproductive capacity.

Why It Matters

Understanding how the HPG axis responds to stimulation like Kisspeptin-10 across different age groups is crucial for addressing age-related reproductive health issues. This research provides foundational insights into the physiological changes underlying male infertility and hypogonadism in older men. The findings could pave the way for developing targeted therapeutic strategies to restore or enhance reproductive function in aging males. Future research should focus on quantifying specific hormonal responses and potentially moving towards larger Phase II or Phase III human trials to validate these age-dependent effects and explore clinical applications.


kisspeptin kisspeptin receptor agonist hpg-axis dose mentioned
Source: clinicaltrials:NCT03315325 · Ingested 2026-04-24 · Digest: gemini-2.5-flash